Acetazolamide
- Product NDC
- 25021-839
- 11-digit product format
- 250210839
- Labeler code
- 25021
- Product ID
- 25021-839_2b64b799-67b1-41b7-ad0d-7c160c6efd58
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide Sodium
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA219775
- Marketing category
- ANDA
- Marketing start
- 2026-01-15
- Substance
- ACETAZOLAMIDE SODIUM
- Active strength
- 500 mg/5mL
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetazolamide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE SODIUM | 500 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 429ZT169UH |
| Rxcui | 307702 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 25021-839-20 | Acetazolamide | 5 mL in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 5 | | 1 |
| 25021-839-20 | Acetazolamide | 1 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 1 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 25021-839-20 | 25021083920 | 1 VIAL in 1 CARTON (25021-839-20) / 5 mL in 1 VIAL | 1 vial | 2026-01-15 | No | No | Historical |